Clinical Trial Update: Lactobacillus GG in Pediatric Ulcerative Colitis (UC) [Phase 2]

View source ↗

Summary

Phase 2 trial of Lactobacillus GG for pediatric ulcerative colitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Lactobacillus GG (Lactobacillus rhamnosus GG)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Ulcerative Colitis | Phase 2 | Status: WITHDRAWN